Track topics on Twitter Track topics that are important to you
Since it was founded in 1980, Amgen has established itself as a leading global biotechnology company and built increasingly strong human therapeutics brands as well as state of the art manufacturing facilities. This case study analyses the company's recent financial performance, evaluates the strategies that have helped it become a global leader, and explores what the future may hold.
Investigation of Amgen's success and a detailed analysis of its rise to be one of the most innovative biotechnology companies in the world.
Parallel comparisons in terms of RandD, stock market and financial performance to identify its strengths and weaknesses among its peers.
Analysis of the challenges that Amgen faces both internally and externally.
The case study also focuses on the RandD and acquisition strategy of the company.
How did Amgen become the world's leading Biotechnology company?
What are the key challenges the company now faces?
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Bioscience - any of the sciences that deal with living organisms. The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...
Standard antiretroviral therapy (ART) consists of the combination of at least three antiretroviral (ARV) drugs to maximally suppress the HIV virus and stop the progression of HIV disease. Huge reductions have been seen in rates of death and suffering whe...